Literature DB >> 7966162

Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.

H O Kim1, X D Ji, N Melman, M E Olah, G L Stiles, K A Jacobson.   

Abstract

1,3-Dibutylxanthine 7-riboside has been found to be a partial agonist at A3 adenosine receptors (van Galen et al. Mol. Pharmacol. 1994, 45, 1101-1111). 1,3-Dialkylxanthine 7-riboside analogues modified at the 1-, 3-, and 8-purine positions and at the ribose 5'-position were synthesized. The nucleoside analogues were examined for affinity in radioligand binding assays at rat brain A3 adenosine receptors stably expressed in CHO cells, using the radioligand [[125I]-4-amino-3-iodobenzyl]adenosine-5'-N-methyluronamide (AB-MECA). Affinity was assayed at rat brain A1 and A2a receptors using [3H]PIA and [3H]CGS 21680, respectively. The affinity of xanthine 7-ribosides at A3 receptors depended on the 1,3-dialkyl substituents in the order: Pent > or = Bu >> Hx > Pr approximately Me. 1,3-Dipentylxanthine 7-riboside was slightly selective for A3 receptors (2-fold vs A1 and 10-fold vs A2a). 8-Methoxy substitution was tolerated at A3 receptors. 2-Thio vs 2-oxo substitution increased potency at all three subtypes and slightly increased A3 vs A1 selectivity. The 5'-uronamide modification, which was previously found to enhance A3 selectivity in N6-benzyladenosine derivatives, was also incorporated into the xanthine 7-ribosides, with similar results. The affinity of 1,3-dialkylxanthine 7-riboside 5'-uronamides at A3 receptors depended on the N-alkyluronamide substituent in the order: MeNH > EtNH >> NH2 >> Me2N. Affinity of the 5'-uronamides at A3 receptors was dependent on the 1,3-dialkyl substitution in the order: Bu > Pent > Hex. 1,3-Dibutylxanthine 7-riboside 5'-N-methylcarboxamide, with a Ki value of 229 nM at A3 receptors, was 160-fold selective for rat A3 vs A1 receptors and > 400-fold selective vs A2a receptors. This derivative acted as a full agonist in the A3 receptor-mediated inhibition of adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966162      PMCID: PMC5875426          DOI: 10.1021/jm00049a021

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  31 in total

Review 1.  Structure and function of A1 adenosine receptors.

Authors:  J Linden
Journal:  FASEB J       Date:  1991-09       Impact factor: 5.191

2.  8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors.

Authors:  M T Shamim; D Ukena; W L Padgett; O Hong; J W Daly
Journal:  J Med Chem       Date:  1988-03       Impact factor: 7.446

3.  Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.

Authors:  C Gallo-Rodriguez; X D Ji; N Melman; B D Siegman; L H Sanders; J Orlina; B Fischer; Q Pu; M E Olah; P J van Galen
Journal:  J Med Chem       Date:  1994-03-04       Impact factor: 7.446

4.  Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.

Authors:  U Schwabe; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

5.  Molecular cloning and characterization of the human A3 adenosine receptor.

Authors:  C A Salvatore; M A Jacobson; H E Taylor; J Linden; R G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.

Authors:  J Linden; H E Taylor; A S Robeva; A L Tucker; J H Stehle; S A Rivkees; J S Fink; S M Reppert
Journal:  Mol Pharmacol       Date:  1993-09       Impact factor: 4.436

7.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart.

Authors:  G S Liu; S C Richards; R A Olsson; K Mullane; R S Walsh; J M Downey
Journal:  Cardiovasc Res       Date:  1994-07       Impact factor: 10.787

Review 9.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Authors:  K A Jacobson; P J van Galen; M Williams
Journal:  J Med Chem       Date:  1992-02-07       Impact factor: 7.446

10.  Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors.

Authors:  K A Jacobson; K L Kirk; W L Padgett; J W Daly
Journal:  J Med Chem       Date:  1985-09       Impact factor: 7.446

View more
  13 in total

1.  A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation.

Authors:  M L Trincavelli; D Tuscano; M Marroni; A Falleni; V Gremigni; S Ceruti; M P Abbracchio; K A Jacobson; F Cattabeni; C Martini
Journal:  Mol Pharmacol       Date:  2002-12       Impact factor: 4.436

Review 2.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

3.  Structure-Based Screening of Uncharted Chemical Space for Atypical Adenosine Receptor Agonists.

Authors:  David Rodríguez; Saibal Chakraborty; Eugene Warnick; Steven Crane; Zhan-Guo Gao; Robert O'Connor; Kenneth A Jacobson; Jens Carlsson
Journal:  ACS Chem Biol       Date:  2016-08-22       Impact factor: 5.100

Review 4.  Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.

Authors:  Kenneth A Jacobson; Athena M Klutz; Dilip K Tosh; Andrei A Ivanov; Delia Preti; Pier Giovanni Baraldi
Journal:  Handb Exp Pharmacol       Date:  2009

5.  A3-adenosine receptors: design of selective ligands and therapeutic prospects.

Authors:  Kenneth A Jacobson; Hea O Kim; Suhaib M Siddiqi; Mark E Olah; Gary L Stiles; Dag K J E von Lubitz
Journal:  Drugs Future       Date:  1995-07       Impact factor: 0.148

6.  Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings.

Authors:  G Ravi; K Lee; X Ji; H S Kim; K A Soltysiak; V E Marquez; K A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2001-09-03       Impact factor: 2.823

7.  A3 Adenosine Receptors: Protective vs. Damaging Effects Identified Using Novel Agonists and Antagonists.

Authors:  Kenneth A Jacobson; Stefano Moro; Yong-Chul Kim; An-Hu Li
Journal:  Drug Dev Res       Date:  1999-03-01       Impact factor: 4.360

8.  Activation and Desensitization of Rat A3-Adenosine Receptors by Selective Adenosine Derivatives and Xanthine-7-Ribosides.

Authors:  Kyung-Sun Park; Carsten Hoffmann; Hea Ok Kim; William L Padgett; John W Daly; Roberta Brambilla; Cristina Motta; Maria P Abbracchio; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1998-06-01       Impact factor: 4.360

9.  Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration.

Authors:  Anna Maria Pugliese; Elisabetta Coppi; Rosaria Volpini; Gloria Cristalli; Renato Corradetti; Lak Shin Jeong; Kenneth A Jacobson; Felicita Pedata
Journal:  Biochem Pharmacol       Date:  2007-06-07       Impact factor: 5.858

10.  A SURVEY OF NONXANTHINE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS.

Authors:  Suhaib M Siddiqi; Xiao-Duo Ji; Neli Melman; Mark E Olah; Rahul Jain; Patricia Evans; Marc Glashofer; William L Padgett; Louis A Cohen; John W Daly; Gary L Stiles; Kenneth A Jacobson
Journal:  Nucleosides Nucleotides       Date:  1996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.